SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is drawing attention for its continued slide to new lows, with traders debating Trump-related political risk ahead of the midterms and skepticism about the companys business fundamentals. Bearish posts dominate, though some traders view the decline as a buying opportunity or expect a bounce.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs stronger-than-expected Q3 results and optimistic 2027 EBITDA outlook are driving the rally, with traders also citing higher steel pricing and improved contracts. Bulls see scope for an earnings recovery and possible short covering, while skeptics question whether the outlook can overcome the companys debt and dependence on steel prices.

AGNC Investment Corp. engages in the operation of a real estate investment trust. The firm invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It also invests in other types of mortgage and mortgage-related securities, such as credit risk transfer securities and non-Agency residential and commercial mortgage-backed securities, where repayment of principal and interest is not guaranteed by the United States government-sponsored enterprise or by the United States Government agency, and other assets related to the housing, mortgage, or real estate markets. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

AGNC Investment Corp

AGNCs Q3 results showed a sharp decline in tangible book value and a loss, while income only narrowly covered the dividend, intensifying concerns about the mortgage REITs valuation and payout sustainability. Traders are debating whether the selloff signals further weakness or a buying opportunity for income investors drawn to the high yield.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious anniversary post and reference to a next chapter sparked speculation among traders about an imminent REGAL trial update or possible deal. Others called it a routine anniversary message and noted that no clinical news was confirmed; the main focus remains REGALs final analysis, triggered at 80 events after the last disclosed count of 78.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Scott Kirbys comments supporting a 100% inheritance tax have drawn angry reactions and boycott calls from some traders. The conversation also centers on Uniteds upcoming quarterly results, with investors debating whether strong travel demand and pricing can offset elevated fuel costs and margin pressure.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Morgan Stanleys upgrade of Amazon to a top pick, citing stronger AWS growth prospects tied to AI demand, is drawing attention alongside the sharp share gain. Traders are upbeat about AWS and AI, while some question whether the analyst call can sustain momentum and are watching for earnings and technical resistance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios expanded FDA approval of ANKTIVA with BCG for papillary-only bladder cancer is the dominant topic, with traders highlighting the larger eligible patient population and debating whether the approval can translate into sales growth. The stocks sharp decline despite the news has prompted sell the news and broad-market explanations, alongside unverified claims of short-selling pressure and concerns about commercialization and financing.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicines Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints in EPP, prompting a sharp rally and renewed optimism about an FDA resubmission. Traders are weighing the strong results against the still-pending regulatory decision and a proposed stock-and-warrant offering that could dilute shareholders, with debate over whether the gains can hold.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is drawing attention after a sharp semiconductor-equipment selloff ahead of its upcoming earnings report. Traders are split between buying the pullback as oversold and expecting more weakness, with results and guidance seen as the next key test of AI- and memory-related equipment demand.

WorldFinancial

Traders are focused on World Liberty Financials banking and USD1 plans, with the reported preliminary bank-charter approval viewed by bulls as a potential catalyst for renewed interest. That optimism is countered by frustration over WLFIs weak, range-bound performance and concerns about Trump-family involvement and possible selling; some traders also speculate that limited circulating supply could amplify a move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHC

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Alignment Healthcare, Inc. (Alignment or the Company) (NasdaqGS: ALHC). On July 8, 2026, reports emerged that a former...

CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?

CVS Health outpaces Alignment Healthcare with stronger returns, rising earnings estimates and a lower valuation as Aetna???s turnaround gains traction.

Monday Sector Leaders: Hospital & Medical Practitioners, Oil & Gas Exploration & Production Stocks

In trading on Monday, hospital & medical practitioners shares were relative leaders, up on the day by about 1.5%. Leading the group were shares of Alignment Healthcare, up about 8.9% and shares of Community Health Systems, up about 3.8% on the day.

Also showing relative st...

Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)

Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC) Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)PR NewswireNEW YORK, Oct. 9, 2026Two...

Alignment Healthcare Stock Hit by Bearish Outlook After Costly Medicare Advantage Rating Downgrade

Alignment Healthcare faces potential stock pressure as its largest Medicare Advantage contract loses its crucial 4-star rating for 2027.read more...

Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. futures rose, but Alignment Healthcare plunged 24% after a Medicare contract downgrade; telecom and other stocks also fell premarket.read more...

Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

Veea jumps 34% after regaining Nasdaq compliance; Freight Technologies leads gainers, while Alignment Healthcare plunges 24% among premarket losers.read more...

HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses

Equity

Humana’s largest Medicare Advantage contract, covering more than 2 million members, rose from 3.5 stars to 4, putting it back above the bonus threshold.


Are Options Traders Betting on a Big Move in Alignment Healthcare Stock?

Investors need to pay close attention to ALHC stock based on the movements in the options market lately.

ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures

ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference Disclosures ALHC ALERT: Hagens Berman Updates Investigation of Alignment Healthcare (NASDAQ: ALHC) Following Baird Conference DisclosuresPR NewswireSAN FRANCISCO, Sept. 23, 2026 SAN...

Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.

Alignment Healthcare Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Alignment Healthcare’s largest California contract, H3815, fell from 4 stars to 3.5.</li><li>Aetna said more than 69% of its Medicare Advantage members are in 2027 plans rated 4 stars or higher, and President Steve Nelson said the results “highlight our distinction in the market.”</li><li>Crossing 4 on CMS star rating unlocks bonus payments that raise the federal money an insurer receives per member.</li></ul><p>Humana (HUM) shares surged as much as 13% in after-hours trading Thursday after the Centers for Medicare &amp; Medicaid Services released 2027 Medicare Advantage star ratings, a quality scorecard that decides which plans earn extra federal bonus payments, while Alignment Healthcare (ALHC) tumbled 23% after its largest contract fell below that cutoff.</p><p>CVS Health fell about 3% in extended trading, and Clover Health rose about 10%.</p><h2 class="st-heading-2">Why The Stars Move The Stocks</h2><p>Medicare Advantage is the private version of Medicare. CMS scores each contract from 1 to 5 stars on measures such as clinical outcomes, member experience, and how the plan is run. The 4-star mark is the cutoff that matters to investors. Crossing it unlocks bonus payments that raise the federal money an insurer receives per member. Dropping below it takes that bonus away.</p><p>The ratings published Thursday do not change this year’s results. They feed payments in 2028, which is why a single half-star move on a large contract can be worth hundreds of millions of dollars.</p><h2 class="st-heading-2">Humana Clears The Bonus Line</h2><p>Humana was the clearest winner. Its largest Medicare Advantage contract, covering more than 2 million members, rose from 3.5 stars to 4, putting it back above the bonus threshold, CMS data showed.</p><p>The rebound matters because Humana was hit hard the last time CMS published ratings. In October 2024, the share of its members in plans rated 4 stars or higher fell from 94% to 25%, after a large contract dropped from 4.5 stars to 3.5. That cut the bonus payments the company was set to receive in 2026. Thursday’s recovery puts that large contract back in line for bonuses in 2028.</p><h2 class="st-heading-2">Alignment And CVS Lose Ground</h2><p>Alignment Healthcare moved the other way. Its largest California contract, H3815, fell from 4 stars to 3.5. That contract accounted for about 81% of membership, so the downgrade knocked most of the company off the bonus list even though six of its seven rated contracts still scored 4 stars or higher, including three at 4.5. Dawn Maroney, president of Alignment Health, said the California rating “is inconsistent with that performance” and that the company “intend[s] to pursue all available administrative remedies and to litigate the measures and methodologies we believe warrant review,” while remaining confident it can return the contract to at least 4 stars.</p><p>CVS, through its Aetna unit, also lost ground. Aetna said more than 69% of its Medicare Advantage members are in 2027 plans rated 4 stars or higher, and President Steve Nelson said the results “highlight our distinction in the market” and give the company confidence it can return to “appropriate margins.” The smaller stock move reflected a broader book than Alignment’s, so a slip on part of it does not rewrite the whole company’s 2028 revenue.</p><p>Clover Health said CMS gave the plans covering about 98% of its members a 5-star rating for 2027, the score that sets 2028 payments. A smaller plan scored 4.5 stars. The 5-star score leaves out 20 measures a federal judge told CMS not to count in a May ruling that the agency has appealed. With those measures included, Clover said, the larger plans would have scored 4.5 stars.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around HUM and ALHC was 'bullish' at the time of writing.</p><p>While <a class="mention" data-mention="$HUM" data-symbol-id="HUM" href="https://stocktwits.com/symbol/HUM" target="_blank">HUM stock</a> has gained 51% year-to-date, CVS added 11%, and CLOV 95%. ALHC, in the meantime, has fallen 56%</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/t-tmus-vz-stocks-plunge-after-hours-as-space-x-buys-800-m-hz-spectrum-for-starlink-mobile/cZDUxmJRBV5">T, TMUS, VZ Stocks Plunge After-Hours As SpaceX Buys 800 MHz Spectrum For Starlink Mobile</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

 Stethoscope with medicare form with parts list. Source: Getty Images

Humana’s largest Medicare Advantage contract, covering more than 2 million members, rose from 3.5 stars to 4, putting it back above the bonus threshold.

Clover Health Investments Corp

CVS Health Corp

Humana Inc

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$8.40
Prev Close	$8.28
Open	$8.26
Dividend Yield	0.00%
50-Day Moving Average	$10.94
Beta	0.33
Avg. Volume	11.19M
PE Ratio	44.35

52-Week High	$25.12
52-Week Low	$6.01
Market Capitalization	$1.72B
EPS (Annual)	-$0.0037
Price to Book	6.47
Revenue Per Employee	$2.14M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALHC Fundamentals